Prevalence of multiple sclerosis and its risks in Tehran, Iran, in 2019

被引：0
|
作者：
Mohamadreza Nasiri
Hossein Maroufi
Mohammad Ali Sahraian
Sharareh Eskandarieh
机构：
[1] Tehran University of Medical Sciences,Multiple Sclerosis Research Center, Neuroscience Institute
来源：
Neurological Sciences | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2575 / 2576
页数：1
相关论文
共 50 条
  • [31] Prevalence and incidence of multiple sclerosis in Ardabil, Northwest of Iran
    Molazadeh, Negar
    Mohebi, Farnam
    Altafi, Davar
    Sahraian, Mohammad Ali
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
  • [32] Childhood and juvenile onset multiple sclerosis in Tehran, Iran: Report of 150 cases
    Lotfi, J.
    Alikhani, K.
    Hooshmand, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 13 - 13
  • [33] Prevalence of Multiple Sclerosis (MS) in Zanjan Province of Iran
    Ghajarzadeh, Mahsa
    Foroushani, Abbas R.
    Ghezelbash, Parviz
    Ghoreishi, Abdoreza
    Maghbooli, Mehdi
    Yousefi, Mehran
    Rahgoshai, Babak K.
    Maemodan, Farhad G.
    Mohammadifar, Mehdi
    Sahraian, Mohammad A.
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2020, 11 (01)
  • [34] Significant Increase in the Prevalence of Multiple Sclerosis in Iran in 2011
    Izadi, Sadegh
    Nikseresht, Alireza
    Sharifian, Maryam
    Sahraian, Mohammad Ali
    Jahromi, Alireza Hamidian
    Aghighi, Mohammad
    Heidary, Alireza
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2014, 39 (02) : 152 - 153
  • [35] Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies
    W. Daniel Chapman
    Megan C. Herink
    Michelle H. Cameron
    Dennis Bourdette
    Current Neurology and Neuroscience Reports, 2023, 23 : 521 - 529
  • [36] Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies
    Chapman, W. Daniel
    Herink, Megan C.
    Cameron, Michelle H.
    Bourdette, Dennis
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2023, 23 (09) : 521 - 529
  • [37] Estimation the medical cost of multiple sclerosis in Iran; 2019–2020
    Mina Asadollahi
    Ali Darvishi
    Amirreza Azimi
    Majid Annabi
    Zahra Jafariazar
    Ramin Heshmat
    BMC Health Services Research, 22
  • [38] Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020)
    Razazian, Nazanin
    Eskandarieh, Sharareh
    Siabani, Soraya
    Afshari, Daryoush
    Sahraian, Mohammad-Ali
    Khezri, Orkideh
    Rezaei, Mansour
    Fakhri, Negin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
  • [39] Do socioeconomic factors affect the prevalence of multiple sclerosis in Iran?
    Pakdel, Manizhe
    Hedstrom, Anna Karin
    Bidkhori, Mohammad
    Hadei, Mostafa
    Moghaddam, Vahid Kazemi
    Sarmadi, Mohammad
    Zohdi, Sara
    Marufi, Nilufar
    ACTA NEUROLOGICA SCANDINAVICA, 2019, 140 (05): : 328 - 335
  • [40] Prevalence of multiple sclerosis and environmental factors in Kerman province, Iran
    Ebrahimi, Hossein Ali
    Sedighi, Behnaz
    NEUROLOGY ASIA, 2013, 18 (04) : 385 - 389
12345